Review
Version 1
This version is not peer-reviewed
Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update
Version 1
: Received: 16 July 2020 / Approved: 17 July 2020 / Online: 17 July 2020 (14:01:21 CEST)
A peer-reviewed article of this Preprint also exists.
Balgoma, D.; Gil-de-Gómez, L.; Montero, O. Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update. Metabolites 2020, 10, 356. Balgoma, D.; Gil-de-Gómez, L.; Montero, O. Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update. Metabolites 2020, 10, 356.
Abstract
Recent COVID-19 outbreak has come into prominence the pathogenetic mechanisms underlying the Biology and Biochemistry of viral infections. COVID-19 illness is brought about by infection with the severe acute respiratory syndrome coronavirus SARS-CoV-2 [1,2], an enveloped positive single stranded RNA virus (ssRNA+). From a lipidomics viewpoint, there is a variety of mechanisms involving virus infection that encompass virus entry, disturbance of host cell lipid metabolism, and the role played by diverse lipids in regard to the infection effectiveness. All these aspects have currently been tackled separately as independent issues and focusing on the function of proteins. Here we review the role of cholesterol and other lipids in in ssRNA+ and SARS-COV-2 infection.
Keywords
Lipidomics; ssRNA+ virus; membrane fusion; lipid metabolism; cholesterol; sphingolipids; phosphatidylinositol
Subject
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment